Abstract:Background: Accurate interpretation of BRCA1/2 variants is critical for risk assessment, enhanced cancer surveillance, prevention strategies, and precise clinical treatment of breast cancer. However, current worldwide standards depend primarily on sequencing information from Caucasian populations.Methods: Panel-based sequencing served to detect BRCA1/2 variants in a Chinese multicenter cohort of 21,216 breast cancer patients (BCs) and 6,434 healthy controls (HCs).Findings: 1,245 pathogenic variants of BRCA1/2, 262 of which were novel (21.04%), and 2,517 variants of uncertain significance (VUS) were identified. Unlike in the Caucasian population, BRCA2 variants were more frequent than BRCA1 variants (56.34% versus 43.66%). The 48 most common variants accounted for 39.86% of all pathogenic variants, and were not reported as common variants in Caucasians. Furthermore, we unambiguously reclassified VUS in 508 subjects, lowering the VUS ratio from 9.05% to 7.21%. Pathogenic BRCA1/2 variants correlated with younger onset age, higher frequencies of bilateral and triple-negative BC, invasive carcinomas, high histological grades, and family history of BC and other cancers.Interpretation: Strong ethnicity-specific occurrences of pathogenic BRCA1/2 variants were identified in the Chinese population. Hence, the findings provide rationale and sequencing information for the implementation of BRCA1/2 variants tailored to the Chinese population into clinical risk assessment.Funding Statement: National Natural Science Foundation of China 81772802, Shanghai science and technology innovation action plan of China 17JC1404400 and 16DZ19102, Special Funds for Technological Innovation of Shanghai Jiao Tong University YG2016MS22, Chinese Academy of Science XDA12020223 (W.H.X), Natural Science Foundation of Zhejiang Province LZ16H160002 (C.Y.D), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (C.Y.D).Declaration of Interests: Authors declare no potential conflicts of interest.Ethics Approval Statement: The study was approved by the Ethics Committee of all the hospitals involved and was performed according to the Declaration of Helsinki Principles. Written consent to notify blood samples for future research was obtained for each patient under the Institutional Review Board (IRB)-approved protocol.

Rare variants discovery by extensive whole-genome sequencing of the Han Chinese population in Taiwan: Applications to cardiovascular medicine

Complete genomic profiles of 1496 Taiwanese reveal curated medical insights

Complete genomic profiles of 1,496 Taiwanese reveal curated medical insights

Prevalence and Reclassification of BRCA1 and BRCA2 Variants in a Large, Unselected Chinese Han Breast Cancer Cohort

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Whole Genome Analyses of Chinese Population and De Novo Assembly of A Northern Han Genome

Deep Whole-Genome Sequencing of 90 Han Chinese Genomes

Population-Specific Polygenic Risk Scores Developed for the Han Chinese

Genetic Structure of the Han Chinese Population Revealed by Genome-wide SNP Variation

Comprehensive Characterization of Human Genome Variation by High Coverage Whole-Genome Sequencing of Forty Four Caucasians

Assessing genome-wide copy number variation in the Han Chinese population.

Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies

Comprehensive Structural Variant Haplotype Panel of 943 Han Chinese from Long-Read Whole-Genome Sequencing

Detecting Genetic Ancestry and Adaptation in the Taiwanese Han People

A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan

Deleterious Variants Contribute Minimal Excess Risk in Large-Scale Testing

Association Analysis Identifies New Risk Loci for Congenital Heart Disease in Chinese Populations

Genome-Wide Association Study on the Hematological Phenotypic Characteristics of the Han Population from Northwest China

RETRACTED ARTICLE: 11,670 Whole-Genome Sequences Representative of the Han Chinese Population from the CONVERGE Project

Long-read sequencing of 945 Han individuals identifies novel structural variants associated with phenotypic diversity and disease susceptibility

Investigation of Associations Between Ten Polymorphisms and the Risk of Coronary Artery Disease in Southern Han Chinese